Suitors Weigh Bids for Sanofi's $3B European Generics Biz Post author:Sam Post published:January 10, 2018 Post category:BioPharma The portfolio consists of acute, chronic and oncology products. Source: BioSpace You Might Also Like Bay Area Biotech Forges Exclusive Pact With Zai Lab for Gastric Cancer Drug Development December 19, 2017 GlaxoSmithKline's Pain in China is AstraZeneca's Gain November 8, 2017 A Win for venBio as Judge Hits Pause on Immunomedics's $2 Billion Deal With Seattle Genetics March 9, 2017
Bay Area Biotech Forges Exclusive Pact With Zai Lab for Gastric Cancer Drug Development December 19, 2017
A Win for venBio as Judge Hits Pause on Immunomedics's $2 Billion Deal With Seattle Genetics March 9, 2017
